Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia

Background: Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprolactinema and may result in patients having unnecessary investigations and imaging. We report the results of cannulated prolactin tests with serial prolactin measurements from an indwelling catheter to...

Full description

Saved in:
Bibliographic Details
Published in:Clinical medicine insights. Endocrinology and diabetes 2021, Vol.14, p.11795514211025276-11795514211025276
Main Authors: Almazrouei, Raya, Zaman, Shamaila, Wernig, Florian, Meeran, Karim
Format: Article
Language:English
Subjects:
Diagnostic tests
Endocrine system
Original Research
Phlebotomy
Physical growth
Pituitary gland
Stress
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c532t-4b95e3139b4e0b05fb4c1cb8f1aea248d0ea36e30068184319262b9e5d5f01953
cites cdi_FETCH-LOGICAL-c532t-4b95e3139b4e0b05fb4c1cb8f1aea248d0ea36e30068184319262b9e5d5f01953
container_end_page 11795514211025276
container_issue
container_start_page 11795514211025276
container_title Clinical medicine insights. Endocrinology and diabetes
container_volume 14
creator Almazrouei, Raya
Zaman, Shamaila
Wernig, Florian
Meeran, Karim
description Background: Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprolactinema and may result in patients having unnecessary investigations and imaging. We report the results of cannulated prolactin tests with serial prolactin measurements from an indwelling catheter to differentiate true from stress-induced hyperprolactinemia in patients with persistently mildly elevated prolactin levels in both referral and repeat samples. Methods: Data were collected for 42 patients who had a cannulated prolactin test between January 2017 and May 2018. After cannula insertion, prolactin was measured at 0, 60, and 120 minutes. Normalization is defined as a decline in prolactin to gender-defined normal ranges. Results: The mean age was 33.8 years (SD ± 9.9), and 37 (88%) were female. Menstrual irregularities were the main presenting symptom in 28.57% of the patients. Prolactin normalized in 12 (28.6%) patients of whom cannulated prolactin test was done. Repeat random prolactin levels were significantly higher in patients whose prolactin did not normalize during the cannulated prolactin test. MRI of the pituitary gland showed an abnormality in 23 out of 28 (82%) patients who did not normalize prolactin, a microadenoma in the majority of patients (18 patients). Conclusion: The cannulated prolactin test was useful in excluding true hyperprolactinemia in 28.6% of patients with previously confirmed mildly elevated random prolactin on two occasions, thus avoiding over-diagnosis and unnecessary imaging.
doi_str_mv 10.1177/11795514211025276
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_17d3c4d21d754add8a6f7770da1b2bce</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_11795514211025276</sage_id><doaj_id>oai_doaj_org_article_17d3c4d21d754add8a6f7770da1b2bce</doaj_id><sourcerecordid>2612671105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-4b95e3139b4e0b05fb4c1cb8f1aea248d0ea36e30068184319262b9e5d5f01953</originalsourceid><addsrcrecordid>eNp1kstuEzEUhkcIRKvSB2CDLLFhk-LreGaDhKLSVioiEnRt-XImdeSMg-2B5u1xmra0XLywj37_57OPfZrmNcEnhEj5vk69EIRTQjAVVLbPmsOdNtuJzx_FB81xzitcB-8ZE-xlc8A4pZhicdjcXBUffNmiOKC5Hscp6AIOLVIM2hY_ohLR6Y0NkwP0tSTIGZ1vN5A29wZYe42qb6GLh7Fk9NOXa7SAlH0uVUCffXD_yHnVvBh0yHB8tx41V59Ov83PZ5dfzi7mHy9nVjBaZtz0AhhhveGADRaD4ZZY0w1Eg6a8cxg0a4Fh3Hak44z0tKWmB-HEgEkv2FFzsee6qFdqk_xap62K2qtbIaal0ql4G0AR6ZjljhInBdfOdbodpJTYaWKosVBZH_aszWTW4GwtL-nwBPp0Z_TXahl_qI5S0sq-At7dAVL8PkEuau2zhRD0CHHKigretYwKLKv17R_WVZzSWJ9K0ZbQVtZv31VH9i6bYs4JhofLEKx2baL-apOa8-ZxFQ8Z901RDSd7Q9ZL-H3s_4m_AKtexq4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2612671105</pqid></control><display><type>article</type><title>Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia</title><source>Publicly Available Content Database</source><source>Sage Journals GOLD Open Access 2024</source><source>PubMed Central</source><creator>Almazrouei, Raya ; Zaman, Shamaila ; Wernig, Florian ; Meeran, Karim</creator><creatorcontrib>Almazrouei, Raya ; Zaman, Shamaila ; Wernig, Florian ; Meeran, Karim</creatorcontrib><description>Background: Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprolactinema and may result in patients having unnecessary investigations and imaging. We report the results of cannulated prolactin tests with serial prolactin measurements from an indwelling catheter to differentiate true from stress-induced hyperprolactinemia in patients with persistently mildly elevated prolactin levels in both referral and repeat samples. Methods: Data were collected for 42 patients who had a cannulated prolactin test between January 2017 and May 2018. After cannula insertion, prolactin was measured at 0, 60, and 120 minutes. Normalization is defined as a decline in prolactin to gender-defined normal ranges. Results: The mean age was 33.8 years (SD ± 9.9), and 37 (88%) were female. Menstrual irregularities were the main presenting symptom in 28.57% of the patients. Prolactin normalized in 12 (28.6%) patients of whom cannulated prolactin test was done. Repeat random prolactin levels were significantly higher in patients whose prolactin did not normalize during the cannulated prolactin test. MRI of the pituitary gland showed an abnormality in 23 out of 28 (82%) patients who did not normalize prolactin, a microadenoma in the majority of patients (18 patients). Conclusion: The cannulated prolactin test was useful in excluding true hyperprolactinemia in 28.6% of patients with previously confirmed mildly elevated random prolactin on two occasions, thus avoiding over-diagnosis and unnecessary imaging.</description><identifier>ISSN: 1179-5514</identifier><identifier>EISSN: 1179-5514</identifier><identifier>DOI: 10.1177/11795514211025276</identifier><identifier>PMID: 34220205</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Diagnostic tests ; Endocrine system ; Original Research ; Phlebotomy ; Physical growth ; Pituitary gland ; Stress ; Tumors</subject><ispartof>Clinical medicine insights. Endocrinology and diabetes, 2021, Vol.14, p.11795514211025276-11795514211025276</ispartof><rights>The Author(s) 2021</rights><rights>The Author(s) 2021.</rights><rights>The Author(s) 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2021 2021 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-4b95e3139b4e0b05fb4c1cb8f1aea248d0ea36e30068184319262b9e5d5f01953</citedby><cites>FETCH-LOGICAL-c532t-4b95e3139b4e0b05fb4c1cb8f1aea248d0ea36e30068184319262b9e5d5f01953</cites><orcidid>0000-0003-0878-1123</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221679/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2612671105?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,4010,21947,25734,27834,27904,27905,27906,36993,36994,44571,44926,45314,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34220205$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Almazrouei, Raya</creatorcontrib><creatorcontrib>Zaman, Shamaila</creatorcontrib><creatorcontrib>Wernig, Florian</creatorcontrib><creatorcontrib>Meeran, Karim</creatorcontrib><title>Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia</title><title>Clinical medicine insights. Endocrinology and diabetes</title><addtitle>Clin Med Insights Endocrinol Diabetes</addtitle><description>Background: Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprolactinema and may result in patients having unnecessary investigations and imaging. We report the results of cannulated prolactin tests with serial prolactin measurements from an indwelling catheter to differentiate true from stress-induced hyperprolactinemia in patients with persistently mildly elevated prolactin levels in both referral and repeat samples. Methods: Data were collected for 42 patients who had a cannulated prolactin test between January 2017 and May 2018. After cannula insertion, prolactin was measured at 0, 60, and 120 minutes. Normalization is defined as a decline in prolactin to gender-defined normal ranges. Results: The mean age was 33.8 years (SD ± 9.9), and 37 (88%) were female. Menstrual irregularities were the main presenting symptom in 28.57% of the patients. Prolactin normalized in 12 (28.6%) patients of whom cannulated prolactin test was done. Repeat random prolactin levels were significantly higher in patients whose prolactin did not normalize during the cannulated prolactin test. MRI of the pituitary gland showed an abnormality in 23 out of 28 (82%) patients who did not normalize prolactin, a microadenoma in the majority of patients (18 patients). Conclusion: The cannulated prolactin test was useful in excluding true hyperprolactinemia in 28.6% of patients with previously confirmed mildly elevated random prolactin on two occasions, thus avoiding over-diagnosis and unnecessary imaging.</description><subject>Diagnostic tests</subject><subject>Endocrine system</subject><subject>Original Research</subject><subject>Phlebotomy</subject><subject>Physical growth</subject><subject>Pituitary gland</subject><subject>Stress</subject><subject>Tumors</subject><issn>1179-5514</issn><issn>1179-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kstuEzEUhkcIRKvSB2CDLLFhk-LreGaDhKLSVioiEnRt-XImdeSMg-2B5u1xmra0XLywj37_57OPfZrmNcEnhEj5vk69EIRTQjAVVLbPmsOdNtuJzx_FB81xzitcB-8ZE-xlc8A4pZhicdjcXBUffNmiOKC5Hscp6AIOLVIM2hY_ohLR6Y0NkwP0tSTIGZ1vN5A29wZYe42qb6GLh7Fk9NOXa7SAlH0uVUCffXD_yHnVvBh0yHB8tx41V59Ov83PZ5dfzi7mHy9nVjBaZtz0AhhhveGADRaD4ZZY0w1Eg6a8cxg0a4Fh3Hak44z0tKWmB-HEgEkv2FFzsee6qFdqk_xap62K2qtbIaal0ql4G0AR6ZjljhInBdfOdbodpJTYaWKosVBZH_aszWTW4GwtL-nwBPp0Z_TXahl_qI5S0sq-At7dAVL8PkEuau2zhRD0CHHKigretYwKLKv17R_WVZzSWJ9K0ZbQVtZv31VH9i6bYs4JhofLEKx2baL-apOa8-ZxFQ8Z901RDSd7Q9ZL-H3s_4m_AKtexq4</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Almazrouei, Raya</creator><creator>Zaman, Shamaila</creator><creator>Wernig, Florian</creator><creator>Meeran, Karim</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AYAGU</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0878-1123</orcidid></search><sort><creationdate>2021</creationdate><title>Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia</title><author>Almazrouei, Raya ; Zaman, Shamaila ; Wernig, Florian ; Meeran, Karim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-4b95e3139b4e0b05fb4c1cb8f1aea248d0ea36e30068184319262b9e5d5f01953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Diagnostic tests</topic><topic>Endocrine system</topic><topic>Original Research</topic><topic>Phlebotomy</topic><topic>Physical growth</topic><topic>Pituitary gland</topic><topic>Stress</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Almazrouei, Raya</creatorcontrib><creatorcontrib>Zaman, Shamaila</creatorcontrib><creatorcontrib>Wernig, Florian</creatorcontrib><creatorcontrib>Meeran, Karim</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Australia &amp; New Zealand Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Clinical medicine insights. Endocrinology and diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Almazrouei, Raya</au><au>Zaman, Shamaila</au><au>Wernig, Florian</au><au>Meeran, Karim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia</atitle><jtitle>Clinical medicine insights. Endocrinology and diabetes</jtitle><addtitle>Clin Med Insights Endocrinol Diabetes</addtitle><date>2021</date><risdate>2021</risdate><volume>14</volume><spage>11795514211025276</spage><epage>11795514211025276</epage><pages>11795514211025276-11795514211025276</pages><issn>1179-5514</issn><eissn>1179-5514</eissn><abstract>Background: Stress-induced hyperprolactinemia can be difficult to differentiate from true hyperprolactinema and may result in patients having unnecessary investigations and imaging. We report the results of cannulated prolactin tests with serial prolactin measurements from an indwelling catheter to differentiate true from stress-induced hyperprolactinemia in patients with persistently mildly elevated prolactin levels in both referral and repeat samples. Methods: Data were collected for 42 patients who had a cannulated prolactin test between January 2017 and May 2018. After cannula insertion, prolactin was measured at 0, 60, and 120 minutes. Normalization is defined as a decline in prolactin to gender-defined normal ranges. Results: The mean age was 33.8 years (SD ± 9.9), and 37 (88%) were female. Menstrual irregularities were the main presenting symptom in 28.57% of the patients. Prolactin normalized in 12 (28.6%) patients of whom cannulated prolactin test was done. Repeat random prolactin levels were significantly higher in patients whose prolactin did not normalize during the cannulated prolactin test. MRI of the pituitary gland showed an abnormality in 23 out of 28 (82%) patients who did not normalize prolactin, a microadenoma in the majority of patients (18 patients). Conclusion: The cannulated prolactin test was useful in excluding true hyperprolactinemia in 28.6% of patients with previously confirmed mildly elevated random prolactin on two occasions, thus avoiding over-diagnosis and unnecessary imaging.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>34220205</pmid><doi>10.1177/11795514211025276</doi><orcidid>https://orcid.org/0000-0003-0878-1123</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1179-5514
ispartof Clinical medicine insights. Endocrinology and diabetes, 2021, Vol.14, p.11795514211025276-11795514211025276
issn 1179-5514
1179-5514
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_17d3c4d21d754add8a6f7770da1b2bce
source Publicly Available Content Database; Sage Journals GOLD Open Access 2024; PubMed Central
subjects Diagnostic tests
Endocrine system
Original Research
Phlebotomy
Physical growth
Pituitary gland
Stress
Tumors
title Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T17%3A42%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20of%20Cannulated%20Prolactin%20to%20Exclude%20Stress%20Hyperprolactinemia%20in%20Patients%20with%20Persistent%20Mild%20Hyperprolactinemia&rft.jtitle=Clinical%20medicine%20insights.%20Endocrinology%20and%20diabetes&rft.au=Almazrouei,%20Raya&rft.date=2021&rft.volume=14&rft.spage=11795514211025276&rft.epage=11795514211025276&rft.pages=11795514211025276-11795514211025276&rft.issn=1179-5514&rft.eissn=1179-5514&rft_id=info:doi/10.1177/11795514211025276&rft_dat=%3Cproquest_doaj_%3E2612671105%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c532t-4b95e3139b4e0b05fb4c1cb8f1aea248d0ea36e30068184319262b9e5d5f01953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2612671105&rft_id=info:pmid/34220205&rft_sage_id=10.1177_11795514211025276&rfr_iscdi=true